Published in Proc Natl Acad Sci U S A on May 16, 2003
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature (2005) 6.78
Viral mutation rates. J Virol (2010) 3.87
Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog (2005) 3.41
Quasispecies theory and the behavior of RNA viruses. PLoS Pathog (2010) 3.19
Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J (2004) 3.19
Viral quasispecies evolution. Microbiol Mol Biol Rev (2012) 2.69
Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J Biol Chem (2005) 2.40
Theory of lethal mutagenesis for viruses. J Virol (2007) 2.20
Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A (2010) 1.96
Genome-wide diversity and selective pressure in the human rhinovirus. Virol J (2007) 1.94
Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev (2007) 1.87
Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog (2013) 1.75
Arbovirus high fidelity variant loses fitness in mosquitoes and mice. Proc Natl Acad Sci U S A (2011) 1.73
Plaques Formed by Mutagenized Viral Populations Have Elevated Coinfection Frequencies. MBio (2017) 1.73
Motif D of viral RNA-dependent RNA polymerases determines efficiency and fidelity of nucleotide addition. Structure (2012) 1.71
Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog (2010) 1.67
Viral determinants of resistance to treatment in patients with hepatitis C. Clin Microbiol Rev (2007) 1.65
Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog (2008) 1.65
New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis. Clin Infect Dis (2008) 1.58
Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo. J Virol (2009) 1.58
Selection for robustness in mutagenized RNA viruses. PLoS Genet (2007) 1.58
Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J Virol (2006) 1.56
The role of mutational robustness in RNA virus evolution. Nat Rev Microbiol (2013) 1.54
Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures. J Virol (2010) 1.51
Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase. J Virol (2007) 1.48
Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J Virol (2005) 1.46
Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLoS Pathog (2010) 1.34
T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro. J Virol (2013) 1.34
Coxsackievirus B3 mutator strains are attenuated in vivo. Proc Natl Acad Sci U S A (2012) 1.32
Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc Natl Acad Sci U S A (2006) 1.32
Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA. J Virol (2005) 1.28
The cost of replication fidelity in an RNA virus. Proc Natl Acad Sci U S A (2005) 1.28
Rationalizing the development of live attenuated virus vaccines. Nat Biotechnol (2010) 1.26
Preextinction viral RNA can interfere with infectivity. J Virol (2004) 1.26
Crystal structure of coxsackievirus B3 3Dpol highlights the functional importance of residue 5 in picornavirus polymerases. J Virol (2008) 1.26
Enterovirus infections of the central nervous system. Virology (2011) 1.24
Molecular dynamics simulations of viral RNA polymerases link conserved and correlated motions of functional elements to fidelity. J Mol Biol (2011) 1.22
Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. RNA Biol (2011) 1.18
Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res (2003) 1.18
Lethal mutagenesis of poliovirus mediated by a mutagenic pyrimidine analogue. J Virol (2007) 1.16
A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape. PLoS Pathog (2010) 1.08
Long-range interaction networks in the function and fidelity of poliovirus RNA-dependent RNA polymerase studied by nuclear magnetic resonance. Biochemistry (2010) 1.08
Dynamics: the missing link between structure and function of the viral RNA-dependent RNA polymerase? Curr Opin Struct Biol (2009) 1.07
Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. J Virol (2009) 1.07
Lethal mutagenesis of picornaviruses with N-6-modified purine nucleoside analogues. Antimicrob Agents Chemother (2008) 1.07
Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response. PLoS Pathog (2010) 1.06
A Polymerase mechanism-based strategy for viral attenuation and vaccine development. J Biol Chem (2012) 1.06
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections. PLoS Pathog (2009) 1.05
Structures of coxsackievirus, rhinovirus, and poliovirus polymerase elongation complexes solved by engineering RNA mediated crystal contacts. PLoS One (2013) 1.05
Lethal mutagenesis of bacteria. Genetics (2008) 1.05
Structure-function relationships underlying the replication fidelity of viral RNA-dependent RNA polymerases. J Virol (2014) 1.04
Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis. J Virol (2011) 1.01
Structure of foot-and-mouth disease virus mutant polymerases with reduced sensitivity to ribavirin. J Virol (2010) 1.01
Alphavirus mutator variants present host-specific defects and attenuation in mammalian and insect models. PLoS Pathog (2014) 1.00
RNA virus population diversity, an optimum for maximal fitness and virulence. J Biol Chem (2014) 1.00
Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients. J Virol (2013) 1.00
Therapeutically targeting RNA viruses via lethal mutagenesis. Future Virol (2008) 0.99
Biochemical characterization of the fidelity of poliovirus RNA-dependent RNA polymerase. Virol J (2007) 0.99
Lethal mutagenesis and evolutionary epidemiology. Philos Trans R Soc Lond B Biol Sci (2010) 0.98
Common and unique features of viral RNA-dependent polymerases. Cell Mol Life Sci (2014) 0.97
Exploring the fitness landscape of an RNA virus by using a universal barcode microarray. J Virol (2011) 0.97
Isolation of fidelity variants of RNA viruses and characterization of virus mutation frequency. J Vis Exp (2011) 0.97
Pathways to extinction: beyond the error threshold. Philos Trans R Soc Lond B Biol Sci (2010) 0.97
Genus-specific substitution rate variability among picornaviruses. J Virol (2011) 0.96
Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus. Adv Virus Res (2010) 0.96
The cost of replication fidelity in human immunodeficiency virus type 1. Proc Biol Sci (2007) 0.96
Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin. PLoS One (2010) 0.95
Generation and characterization of influenza A viruses with altered polymerase fidelity. Nat Commun (2014) 0.94
Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment. PLoS One (2009) 0.94
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms. Nat Rev Genet (2015) 0.93
Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice. J Virol (2014) 0.93
Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections. Curr Opin Virol (2014) 0.90
What is the role of motif D in the nucleotide incorporation catalyzed by the RNA-dependent RNA polymerase from poliovirus? PLoS Comput Biol (2012) 0.90
Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture. J Virol (2012) 0.90
Inhibition of enterovirus 71 by adenosine analog NITD008. J Virol (2014) 0.89
Variation in RNA virus mutation rates across host cells. PLoS Pathog (2014) 0.89
RIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replication. PLoS Pathog (2013) 0.88
Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype. J Virol (2013) 0.88
Bypass suppression of small-plaque phenotypes by a mutation in poliovirus 2A that enhances apoptosis. J Virol (2009) 0.87
Recombination in enteroviruses is a biphasic replicative process involving the generation of greater-than genome length 'imprecise' intermediates. PLoS Pathog (2014) 0.87
RNA Recombination Enhances Adaptability and Is Required for Virus Spread and Virulence. Cell Host Microbe (2016) 0.86
Ribavirin-resistant variants of foot-and-mouth disease virus: the effect of restricted quasispecies diversity on viral virulence. J Virol (2014) 0.86
Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity. PLoS Pathog (2013) 0.86
Selection of hepatitis C virus resistant to ribavirin. Virol J (2011) 0.86
Mechanisms of viral mutation. Cell Mol Life Sci (2016) 0.85
Concomitant lethal mutagenesis of human immunodeficiency virus type 1. J Mol Biol (2012) 0.84
Does mutational robustness inhibit extinction by lethal mutagenesis in viral populations? PLoS Comput Biol (2010) 0.83
Effective lethal mutagenesis of influenza virus by three nucleoside analogs. J Virol (2015) 0.83
Sequence-Specific Fidelity Alterations Associated with West Nile Virus Attenuation in Mosquitoes. PLoS Pathog (2015) 0.83
StralSV: assessment of sequence variability within similar 3D structures and application to polio RNA-dependent RNA polymerase. BMC Bioinformatics (2011) 0.83
New small-molecule inhibitors effectively blocking picornavirus replication. J Virol (2014) 0.82
Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system. Virology (2015) 0.82
Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity. J Virol (2015) 0.82
Genomic mutation rates that neutralize adaptive evolution and natural selection. J R Soc Interface (2013) 0.82
Viral Polymerase-Helicase Complexes Regulate Replication Fidelity To Overcome Intracellular Nucleotide Depletion. J Virol (2015) 0.82
Structural dynamics as a contributor to error-prone replication by an RNA-dependent RNA polymerase. J Biol Chem (2014) 0.82
Vaccine-derived mutation in motif D of poliovirus RNA-dependent RNA polymerase lowers nucleotide incorporation fidelity. J Biol Chem (2013) 0.82
Structural features of a picornavirus polymerase involved in the polyadenylation of viral RNA. J Virol (2013) 0.82
Norovirus Polymerase Fidelity Contributes to Viral Transmission In Vivo. mSphere (2016) 0.82
Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science (1989) 15.19
Rates of spontaneous mutation. Genetics (1998) 14.89
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A (1981) 12.00
Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science (1998) 11.23
RNA virus mutations and fitness for survival. Annu Rev Microbiol (1997) 10.06
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med (2000) 5.73
The mechanism of RNA recombination in poliovirus. Cell (1986) 5.35
RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A (2001) 5.21
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science (1996) 5.08
Studies on the biochemical basis of spontaneous mutation. I. A comparison of the deoxyribonucleic acid polymerases of mutator, antimutator, and wild type strains of bacteriophage T4. J Biol Chem (1972) 4.11
Structure of the RNA-dependent RNA polymerase of poliovirus. Structure (1997) 3.88
Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol (1986) 3.15
Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity. J Virol (1986) 2.33
Oligomeric structures of poliovirus polymerase are important for function. EMBO J (2001) 2.27
Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol (2000) 2.26
Poliovirus RNA-dependent RNA polymerase (3Dpol): structural, biochemical, and biological analysis of conserved structural motifs A and B. J Biol Chem (2000) 1.98
Prokaryotic DNA polymerase I: evolution, structure, and "base flipping" mechanism for nucleotide selection. J Mol Biol (2001) 1.88
Genetic studies on the poliovirus 2C protein, an NTPase. A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization. J Mol Biol (1994) 1.59
Guanidine-dependent mutants of poliovirus: identification of three classes with different growth requirements. Virology (1987) 1.58
High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study. J Gastroenterol (2002) 1.57
Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol (2002) 1.52
Control of mutation frequency by bacteriophage T4 DNA polymerase. I. The CB120 antimutator DNA polymerase is defective in strand displacement. J Biol Chem (1976) 1.45
Ribavirin quantification in combination treatment of chronic hepatitis C. Antimicrob Agents Chemother (2003) 1.40
Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies. J Virol (2002) 1.35
Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. Ther Drug Monit (2002) 1.34
The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase. Nucleic Acids Res (1998) 1.24
Antimutator mutants in bacteriophage T4 and Escherichia coli. Genetics (1998) 1.16
Mutation of lysine residues in the nucleotide binding segments of the poliovirus RNA-dependent RNA polymerase. J Virol (1996) 1.09
Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential. AIDS (1999) 0.97
One of two NTP binding sites in poliovirus RNA polymerase required for RNA replication. J Biol Chem (1997) 0.96
Identification of nucleotide binding sites in the poliovirus RNA polymerase. Biochemistry (1995) 0.94
Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol (2005) 5.84
Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog (2005) 3.41
The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus. Cell (2013) 3.40
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog (2010) 2.62
Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nat Genet (2005) 2.19
Visualization and functional analysis of RNA-dependent RNA polymerase lattices. Science (2002) 2.14
Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNA-dependent RNA polymerase. J Virol (2002) 1.72
Modification of cellular autophagy protein LC3 by poliovirus. J Virol (2007) 1.71
Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J Virol (2003) 1.62
Role of microtubules in extracellular release of poliovirus. J Virol (2009) 1.49
Similar structural basis for membrane localization and protein priming by an RNA-dependent RNA polymerase. J Biol Chem (2002) 1.48
Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology (2005) 1.47
Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport. Ann Neurol (2012) 1.46
Inhibition of cellular autophagy deranges dengue virion maturation. J Virol (2012) 1.32
Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc Natl Acad Sci U S A (2006) 1.32
Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA. J Virol (2005) 1.28
Potential subversion of autophagosomal pathway by picornaviruses. Autophagy (2007) 1.27
Allosteric effects of ligands and mutations on poliovirus RNA-dependent RNA polymerase. J Virol (2005) 1.11
Intramolecular and intermolecular uridylylation by poliovirus RNA-dependent RNA polymerase. J Virol (2006) 1.03
Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex. J Cell Sci (2007) 1.00
Nucleotide channel of RNA-dependent RNA polymerase used for intermolecular uridylylation of protein primer. J Mol Biol (2006) 0.96
Interstitial contacts in an RNA-dependent RNA polymerase lattice. J Mol Biol (2011) 0.94
Competing pathways control host resistance to virus via tRNA modification and programmed ribosomal frameshifting. Mol Syst Biol (2012) 0.92
Enzymatic and nonenzymatic functions of viral RNA-dependent RNA polymerases within oligomeric arrays. RNA (2010) 0.91
Intracellular topology and epitope shielding of poliovirus 3A protein. J Virol (2004) 0.87
Bypass suppression of small-plaque phenotypes by a mutation in poliovirus 2A that enhances apoptosis. J Virol (2009) 0.87
Complete three-dimensional structures of picornaviral RNA-dependent RNA polymerases. Structure (2004) 0.80
Double-membraned liposomes sculpted by poliovirus 3AB protein. J Biol Chem (2013) 0.77
Nonlytic spread of naked viruses. Autophagy (2015) 0.75